Scilex Holding (SCLX) EPS (Diluted) (QoQ) (2021 - 2026)

Scilex Holding (SCLX) EPS (Diluted) (QoQ) (2021 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 99.79%
Dec 31, 2025 86.46%
Sep 30, 2025 -198.67%
Jun 30, 2025 -229.13%
Mar 31, 2025 -56,156.18%
Dec 31, 2024 99.67%
Sep 30, 2024 88.95%
Jun 30, 2024 -31.36%
Mar 31, 2024 -144,823.95%
Dec 31, 2023 73.96%
Sep 30, 2023 -237.54%
Jun 30, 2023 13.93%
Mar 31, 2023 99.84%
Dec 31, 2022 -8,264.84%
Sep 30, 2022 257.39%
Jun 30, 2022 -1,408.46%
Mar 31, 2022 96.72%
Dec 31, 2021 -12,734.49%
Sep 30, 2021 65.94%
Jun 30, 2021 -11.65%